Condition 1: Stomach Cancer. Condition 2: Esophagus cancer. Condition 3: Malignant neoplasm of small intestine. Condition 4: Malignant neoplasm of colon. Condition 5: Malignant neoplasm of rectum. Condition 6: Malignant neoplasm of liver and intrahepatic bile ducts. Condition 7: Malignant neoplasm of bronchus and lung. Condition 8: Malignant neoplasm of heart, mediastinum and pleura. Condition 9: Breast cancer. Malignant neoplasm of stomach Malignant neoplasm of esophagus Malignant neoplasm o
Conditions
Interventions
Intervention 1: Intervention group: 32 patients will be selected according to the inclusion criteria, using the available sampling method, who come in different work shifts and on different days of th
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Cancer diagnosis recorded in the patient`s medical records Receiving at least two courses of chemotherapy drugs. Receiving drugs that suppress the bone marrow and cause pancytopenia with the approval and supervision of a respected oncology doctor. Age above 18 years. Consent to participate in the study. Physical and hemodynamics stability.
Exclusion criteria
Exclusion criteria: Having a history of cardiovascular diseases, asthma and diabetes. Having any major disabling medical and psychiatric conditions that would interfere with the evaluation. Having a history of allergy to honey and honey products. Age over 60 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood cell count includes the count of white blood cells, red blood cells, hemoglobin and platelets, which will be evaluated according to laboratory results. Timepoint: After the end of the second round of chemotherapy, the intervention is carried out using royal jelly and placebo for five days. After two weeks from the end of the intervention, direct evaluation will be done by the researcher. Method of measurement: Counting blood cells using laboratory results (CBC). | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatigue is evaluated using the Smet's Multidimensional Fatigue Assessment Questionnaire, which ranges from 20 to 100, and a higher score indicates more fatigue. Timepoint: After the end of the second round of chemotherapy, the intervention is carried out using royal jelly and placebo for five days. After two weeks from the end of the intervention, direct evaluation will be done by the researcher. Method of measurement: assessing fatigue using a 20-item questionnaire, Smet's multidimensional measurement of fatigue (Multidimensional Fatigue Inventory). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Ghane
Zanjan University of Medical Sciences
Outcome results
None listed